Stepan Company reported a 64% increase in net income to $17.8 million for Q3 2026, driven by 7% organic sales volume growth and savings from its Project Catalyst restructuring. Adjusted EBITDA rose 18% to $66.3 million, with strong gains in surfactants and polymers segments. Despite a year-to-date loss due to a $76.1 million restructuring charge, the company expects full-year adjusted EBITDA growth, positive free cash flow, and debt reduction. Stepan continues to navigate global economic uncertainties while focusing on strategic growth and operational efficiency.
Stepan Company's Q3 2026 results provide context for readers interested in market trends as of Oct 28, 2026 17:12 WIB. On Pluang, 26 of 83 priced Basic Materials-sector US stocks rose while 50 fell. Notable movers include CRH at USD 87.00 with a 1.43% increase, Sibanye Stillwater Ltd at USD 9.29 with a 1.43% decrease and 98% sell order activity, and USA Rare Earth Inc. at USD 10.54 with a 1.35% increase and 80% buy order activity.
Arcutis Biotherapeutics has appointed Dr. Rob Scott, a seasoned pharmaceutical executive with over 40 years of experience, to its Board of Directors. Dr. Scott's expertise in developing and securing approvals for innovative medicines, including derma...
Air Canada and CAE announced the opening of applications on November 1, 2026, for the 2027 Commandante-Judy-Cameron scholarships. These scholarships support up to eight Canadian women pursuing professional pilot or aircraft maintenance technician tra...
The Legacy Lab by Team One released its 2026 Legacy Makers 100 list, identifying brands consumers trust to have their best interests at heart and remain relevant long-term. St. Jude Children's Research Hospital topped the list for the second year. Th...
Circuit Mind has introduced AVE (Agentic Verification Engine), an AI-powered application that verifies printed circuit board (PCB) schematics against datasheets and internal design rules to catch errors early and avoid expensive respins. AVE compleme...
Grabar Law Office is investigating claims against officers and directors of Erasca, Planet Fitness, PROCEPT BioRobotics, and The Simply Good Foods Company for alleged breaches of fiduciary duties. The investigations focus on misleading statements and...
